Lundbeck

Contact
lupichem.lundbeck.com
+390498699311

Lundbeck Pharmaceuticals Italy S.p.A. (LUPI)

Via Quarta Strada 2
35129 Padua
Italy
+390498699311
lupichem.lundbeck.com
Contact
Profile Products News
Contact

About Lundbeck

Lundbeck Pharmaceuticals Italy is an FDA inspected manufacturer of proprietary APIs and cGMP intermediates for the pharmaceutical, veterinary and life science industries.

All our products are manufactured under cGMP's.

LUPI offers contract manufacturing services to many large multinational pharmaceutical companies. Our business is focused on development and manufacturing of APIs and intermediates.

Read more about Lundbeck
Facts about Lundbeck
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Lundbeck

Product portfolio

Show all

News about Lundbeck

Lundbeck

14-Feb-2012 | research and development

Genmab Reaches Second Milestone in Lundbeck Collaboration

€1 million milestone payment to Genmab

Read news
Lundbeck

19-Dec-2011 | business & finance

Genmab announces progress with Lundbeck collaboration

First pre-clinical milestone met in Lundbeck collaboration

Read news
Lundbeck

04-Oct-2011 | business & finance

Lundbeck and Proximagen Sign Strategic Partnership Agreement

H. Lundbeck A/S and Proximagen Group plc

Read news
Lundbeck

09-Sep-2011 | people

Marie-Laure Pochon elected as Lundbeck's new EVP of Commercial Operations

Lundbeck's Executive Management Group reduced from six to four members

Read news
Lundbeck

17-Jun-2011 | research and development

Lundbeck: Nalmefene completes clinical phase III programme

Submission of the European Marketing Authorization Application (MAA) is expected by the end of 2011

Read news
Lundbeck

17-May-2011 | research and development

H. Lundbeck starts clinical phase III study with Lu AA21004 in Japan

H. Lundbeck A/S and Takeda Pharmaceutical Company Limited announced the initiation of a phase III clinical trial in Japan for Lu AA21004 in patients with ...

Read news
Lundbeck

09-Mar-2011 | research and development

FDA accepts Lundbeck's submission of the New Drug Application for clobazam

H. Lundbeck A/S announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the investigational ...

Read news
Lundbeck

10-Feb-2011 | business & finance

Lundbeck expands its commercial opportunities in Canada and Latin America

H. Lundbeck A/S  announced that Lundbeck has been granted commercial rights to several Cephalon products in Canada and Latin America. As part of the ...

Read news
Show more news about Lundbeck

Here you will find Lundbeck Pharmaceuticals Italy S.p.A. (LUPI)